ILD Risk Elevated in RA, PsA After Starting DMARDs ILD Risk Elevated in RA, PsA After Starting DMARDs
The risk for interstitial lung disease in patients with PsA during the first 5 years was five times higher than for the general population, and the risk was not modified by methotrexate use.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 2, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
Health Disparities in the Diagnosis and Treatment of Interstitial Lung Disease Health Disparities in the Diagnosis and Treatment of Interstitial Lung Disease
Toby M. Maher, MD, considers the challenges and inequalities faced by patients with interstitial lung disease.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2023 Category: Consumer Health News Tags: Pulmonary Medicine MDAngle Source Type: news
In Retrospect: The Evolution of Understanding of Interstitial Lung Disease In Retrospect: The Evolution of Understanding of Interstitial Lung Disease
Toby M. Maher, MD, remembers his first encounter with interstitial lung disease and what has changed since.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2023 Category: Consumer Health News Tags: Pulmonary Medicine MDAngle Source Type: news
Innovative Tools to Help Lessen Disparities for Patients With Interstitial Lung Disease Innovative Tools to Help Lessen Disparities for Patients With Interstitial Lung Disease
Rupal J. Shah, MD, addresses the impact that health disparities have on the lives of patients both awaiting a diagnosis of or being treated for interstitial lung disease.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2023 Category: Consumer Health News Tags: Pulmonary Medicine MDAngle Source Type: news
Lessons Learned From a Mentor in Interstitial Lung Disease Lessons Learned From a Mentor in Interstitial Lung Disease
Chidinma Chima-Melton, MD, discusses the importance of taking a thorough patient history in the treatment of interstitial lung disease.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 25, 2023 Category: Consumer Health News Tags: Pulmonary Medicine MDAngle Source Type: news
A Patient Experience That Sparked a Career in Interstitial Lung Disease A Patient Experience That Sparked a Career in Interstitial Lung Disease
Chidinma Chima-Melton, MD, shares a patient experience that opened her eyes toward the rapid progression and problems with diagnosis in patients with interstitial lung disease.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 25, 2023 Category: Consumer Health News Tags: Pulmonary Medicine MDAngle Source Type: news
Establishing Connections in the Management of Interstitial Lung Disease Establishing Connections in the Management of Interstitial Lung Disease
Rupal J. Shah, MD, considers the profound benefits of the patient-clinician relationship in the treatment of interstitial lung disease.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 25, 2023 Category: Consumer Health News Tags: Pulmonary Medicine MDAngle Source Type: news
Drug-induced Interstitial Lung Disease Due to OTC Cold Medicine Taken for 25 Years Drug-induced Interstitial Lung Disease Due to OTC Cold Medicine Taken for 25 Years
Was long-term use of over-the counter cold medicine the cause of this patient ' s diffuse lung disease?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 21, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
Episode 2: Idiopathic Pulmonary Fibrosis: Who Gets an Antifibrotic? Episode 2: Idiopathic Pulmonary Fibrosis: Who Gets an Antifibrotic?
Drs Jeffrey Swigris and Ayodeji Adegunsoye discuss fibrosing interstitial lung disease and treatment challenges for individuals with idiopathic pulmonary fibrosis.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 4, 2023 Category: Consumer Health News Tags: Pulmonary Medicine InDiscussion Source Type: news
Episode 1: Connective Tissue Disease-Interstitial Lung Disease Episode 1: Connective Tissue Disease-Interstitial Lung Disease
Drs Jeffrey Swigris and Sonye Danoff discuss connective tissue disease-related interstitial lung disease (CTD-ILD) to provide context for understanding idiopathic pulmonary fibrosis.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 4, 2023 Category: Consumer Health News Tags: Pulmonary Medicine InDiscussion Source Type: news
New RYBREVANT ® (amivantamab-vmjw) Data Showed Long-Term Clinical Response and Safety in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Who Have Failed Prior Platinum-Based Chemotherapy
COPENHAGEN, DENMARK, March 29, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new long-term data from the CHRYSALIS study evaluating RYBREVANT® (amivantamab-vmjw) in patients with advanced non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) exon 20 insertion mutations whose disease progressed on prior platinum-based chemotherapy.1 Data from the study showed long-term response and safety in this population and were presented in an oral presentation at the 2023 European Lung Cancer Congress (ELCC) (Abstract #779).1In the analysis of the CHRYSALIS study, inve...
Source: Johnson and Johnson - March 29, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Tofacitinib May Reduce Risk of Interstitial Lung Disease in RA Patients
(MedPage Today) -- Tofacitinib (Xeljanz) in patients with rheumatoid arthritis (RA) stood out among several other biologic and targeted synthetic disease-modifying antirheumatic drugs (sDMARDs) when it came to the incidence of interstitial lung... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 21, 2023 Category: Rheumatology Source Type: news
Blood Test Flags ILD in Systemic Sclerosis
(MedPage Today) -- Serum levels of three markers of pulmonary fibrosis pathology were significantly associated with the presence of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc) -- strongly enough to serve as a clinical... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 14, 2023 Category: Rheumatology Source Type: news
FDA approves Roche ’s Actemra for the treatment of COVID-19 in hospitalised adults
Actemra is the first FDA-approved monoclonal antibody to treat COVID-19Since the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra worldwideActemra is approved for this use in more than 30 countries for the treatment of COVID-19Basel, 21 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra ® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalised adult patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasi...
Source: Roche Media News - December 21, 2022 Category: Pharmaceuticals Source Type: news
How effective is CT for diagnosing interstitial lung disease?
The results highlight the fact that more work needs to be done to effectivel...Read more on AuntMinnie.comRelated Reading:
CT plus histopathology boosts the accuracy of ILD diagnosis
AI reconstruction aids lung nodule detection on ultralow-dose CT
Photon-counting CT improves interstitial pneumonia diagnosis
Training helps novice CT readers identify interstitial lung disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 21, 2022 Category: Radiology Source Type: news
